Following a call for tenders from the CHU de Québec–Université Laval (CHU), RayStation has been designated as the treatment planning system for external beam planning at the new state-of-the-art cancer center, which will be located in the center of Quebec City. CHU is the largest university hospital groups in Quebec, providing general and specialized care for around 2 million people.
The new cancer center will be equipped with seven Varian TrueBeam linacs, as well as advanced imaging systems such as CT Sim, MR Sim and PET CT. Four open vaults have been dedicated for stereotactic and adaptive radiation therapy. The majority of this order has been delivered and generated revenue in the first quarter of 2018. The order was also part of the announcement on March 31, 2018, read more here.
RayStation was selected for its adaptive re-planning and automation capabilities, as well as the flexibility to include additional treatment machines in future expansions. Treatment planning integration, high speed and outstanding efficiency were also key factors.
The comprehensive order further includes advanced RayStation features such as deformable registration, dose tracking, multi-criteria optimization, automated breast planning, Plan Explorer and biological optimization. The center will have licenses for 85 simultaneous users, including treatment planners, physicists, radiation oncologists, therapists, simulation therapists and administrators. The center expects to treat their first patients with RayStation in December 2020.
Johan Löf, CEO of RaySearch, says: “This highly advanced center is an excellent match for RayStation, which supports the most cutting-edge techniques and a broad spectrum of treatment machines. The choice made by CHU truly highlights the importance of an independent evaluation and selection of the treatment planning system and the machines. I am fully convinced that this is the future for radiation therapy centers. This is a major order for RaySearch and I look forward to a successful partnership.”
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system and the RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.
To learn more about RaySearch, go to: www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00